CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Human equivalent of the mouse Nude/SCID phenotype: long-term evaluation of immunologic reconstitution after bone marrow transplantation
نویسندگان
چکیده
Human Nude/SCID (severe combined immunodeficiency) is the first severe combined immunodeficiency caused by mutation of thewinged–helix–nude(WHN)gene,which is expressed in the thymus but not in the hematopoietic lineage. The disease is characterized by a T-cell defect, congenital alopecia, and nail dystrophy. A Nude/SCID patient who underwentbonemarrowtransplantationfrom the human leukocyte antigen–identical heterozygote brother was studied to investigate, in thisuniquemodel, the roleof the thymus in immunologic reconstitution. Despite an increase in CD31, CD41, and CD81 cells, CD41 CD45 RA naive lymphocytes were not regenerated. Conversely, naive CD81 cells were normal. After an initial recovery, lymphocyte proliferation to mitogens progressively declined compared with controls and genotypically identical donor cells grown in the WHN1/2 environment. Analysis of the T-cell receptor (TCR) repertoire of CD41 cells revealed that only 3 of 18 Vb families had an altered CDR3 heterogeneity length profile. Conversely, CD81 lymphocytes showed an abnormal distribution in most Vb families. These data indicate that the thymus is differentially required in thereconstitutionofCD41 and CD81 naive subsets and in the maintenance of their TCR repertoire complexity. Taken together, these findings suggest that bone marrow transplantation is ineffective in the long-term cure of this form of SCID. (Blood. 2001;97:880-885)
منابع مشابه
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation
We found 10 individuals from 7 unrelated families among 170 severe combined immunodeficiency (SCID) patients who exhibited 9 different Janus kinase 3 (JAK3) mutations. These included 3 missense and 2 nonsense mutations, 1 insertion, and 3 deletions. With the exception of 1 individual with persistence of transplacentally transferred maternal lymphocytes, all infants presented with a T B NK pheno...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000
Treatment of chronic granulomatous disease (CGD) with myeloablative bone marrow transplantation is considered risky. This study investigated complications and survival according to different risk factors present at transplantation. The outcomes of 27 transplantations for CGD, from 1985 to 2000, reported to the European Bone Marrow Transplant Registry for primary immunodeficiencies were assessed...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Long-term outcome of hepatitis C infection after bone marrow transplantation
Chronic hepatitis C is often asymptomatic, at least during the first decade following hematopoietic stem cell transplantation. Progression to advanced liver disease or cirrhosis in patients surviving more than 10 years is currently thought to be rare. Among 1078 patients who underwent an allogeneic transplantation between January 1973 and January 1995, 96 patients infected by hepatitis C virus ...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes
Allogeneic bone marrow transplantation (BMT) from a genotypically identical family donor is an accepted therapeutic option for homozygous beta-thalassemia. However, only a minority of patients have access to this curative procedure. The aim of this study is to explore the feasibility of matched unrelated transplants in thalassemia and the possibility of reducing the risk of immunologic complica...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Long-term outcome after bone marrow transplantation for severe aplastic anemia
From January 1978 to December 2001, 133 patients with severe aplastic anemia (SAA) underwent non-T cell–depleted allogeneic bone marrow transplantation from an HLA-identical sibling donor, at the Hospital Saint Louis using either the combination of cyclophosphamide (Cy) and thoracoabdominal irradiation (TAI; n 100) or Cy and antithymocyte globulin (ATG; n 33), as a conditioning regimen. With 13...
متن کامل